NCT02762981: A trial that was reported late by Corcept Therapeutics
This trial has reported, although it was 442 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02762981 |
|---|---|
| Title | Phase 1/2 Study of CORT125134 in Combination With Nab-paclitaxel in Patients With Solid Tumors |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | May 23, 2016 |
| Completion date | May 12, 2020 |
| Required reporting date | May 12, 2021, midnight |
| Actual reporting date | July 28, 2022 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | 442 |